discovered that interleukin (IL)‐12, IL‐15 and IL‐18 induce memory‐like NK cells that exhibit augmented killing against AML, regardless of KIR‐ligand interactions, leading to an expanded NK cell pool of AML‐reactive effector cells. The gene discussed is KIR3DL1; the disease is acute myeloid leukemia.